Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Myriad Genetics, Inc. (MYGN)

« Back to company index

MYGN Chatter Timeline

Stock Ticker for MYGN

Most Active Tweeters for MYGN

UserTweets
@otcdynamics 17
@Tickeron 14
@AmericanBanking 13
@stocknewstimes 10
@TranscriptDaily 9

Recent Tweets for MYGN

Tickeron @Tickeron
$MYGN's price moved below its 50-day Moving Average on November 5, 2019. View odds for this and other indicators:… https://t.co/DunOVbbN8F
November 15th 2019, 4:11pm
tradersreport @tradersreport
RT @Tickeron: $MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and oth…
November 14th 2019, 4:11pm
Tickeron @Tickeron
$MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/Vsiymcgu03
November 14th 2019, 4:11pm
AlertTrade @AlertTrade
RT @SwingTradeBot: Outside Day today: $MYGN ... https://t.co/Ya1wmaeD73
November 14th 2019, 3:11pm
SwingTradeBot @SwingTradeBot
Outside Day today: $MYGN ... https://t.co/Ya1wmaeD73
November 14th 2019, 3:11pm
otcdynamics @otcdynamics
$MYGN INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MYGN, TME, and OSTK of Filing https://t.co/gQUZ2hnmyi
November 14th 2019, 3:11pm
joseph_parnes @joseph_parnes
#Short $MYGN 24.21 Failure to refill previous plunge (44-28) set on Sept '19: causative for today's plunge (34-21)… https://t.co/0NSFSRVU29
November 14th 2019, 12:11pm
safersal13 @safersal13
Options are beautiful, I hit $mygn 25c and $dis 42c with straddle....Disney looked bad but I stayed with it until N… https://t.co/1s2QVsPg4K
November 13th 2019, 7:11pm
otcdynamics @otcdynamics
$MYGN Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tencent, https://t.co/IRNSjgLA0Y
November 13th 2019, 6:11pm
Tickeron @Tickeron
$MYGN in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 14, 2019. View odds for t… https://t.co/eIXqG3LWj9
November 13th 2019, 3:11pm
otcdynamics @otcdynamics
$MYGN Pawar Law Group Reminds Investors of NOV. 26 Deadline in Securities Class Action Lawsuit Against Myriad https://t.co/SS3YfKkB4C
November 13th 2019, 3:11pm
otcdynamics @otcdynamics
$MYGN HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant https://t.co/Xm9cgEPnt4
November 12th 2019, 8:11pm
Tickeron @Tickeron
$MYGN enters a Downtrend because Momentum Indicator dropped below the 0 level on November 5, 2019. View odds for th… https://t.co/uNl0zk5Zay
November 12th 2019, 3:11pm
WatchlistN @WatchlistN
Myriad Genetics $MYGN Rating Increased to Strong-Buy at BidaskClub https://t.co/N2TGho5RTC
November 12th 2019, 2:11pm
TickerReport @TickerReport
Myriad Genetics $MYGN Rating Increased to Strong-Buy at BidaskClub https://t.co/IJiZlMdlip
November 12th 2019, 2:11pm
otcdynamics @otcdynamics
$MYGN CLASS ACTION UPDATE for SEE, TME, MYGN and ZEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on https://t.co/Hsy74VQ1Gk
November 12th 2019, 10:11am
MedtechTinaTan @MedtechTinaTan
$MYGN 's GeneSight test was supposed to bring a strong bull case to the company. Now it's feeling the sting of the… https://t.co/HuNi44AIhh
November 12th 2019, 4:11am
otcdynamics @otcdynamics
$MYGN SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, https://t.co/ePxbk3tn6z
November 11th 2019, 6:11pm
Tickeron @Tickeron
$MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/u7P86j1Tuk
November 11th 2019, 3:11pm
newsfilterio @newsfilterio
Myriad Genetics up 5% on positive prenatal screening test data $MYGN https://t.co/FErfhi3K3J
November 11th 2019, 12:11pm
MarketCurrents @MarketCurrents
$MYGN - Myriad Genetics up 5% on positive prenatal screening test data https://t.co/Ma18S6jnIi
November 11th 2019, 12:11pm
gcassidy718 @gcassidy718
$MYGN price movement 4.27 % https://t.co/3H5kqTuzLf
November 11th 2019, 12:11pm
GeniusOClock @GeniusOClock
Planning on buying puts. $MYGN https://t.co/jPuRJDq47A
November 11th 2019, 9:11am
GeniusOClock @GeniusOClock
Stop fucking with my plans $MYGN!
November 11th 2019, 9:11am
otcdynamics @otcdynamics
$MYGN Myriad’s Prequel™ Prenatal Screen Demonstrates High Performance Across All Fetal-Fraction Levels in Women Und https://t.co/pgoXjNsUIy
November 11th 2019, 7:11am
ProVesting @ProVesting
$NVTA $MYGN: Breaking Down The Invitae Short (Podcast): https://t.co/VnGfEQSVJk
November 11th 2019, 7:11am
SeekingAlpha @SeekingAlpha
$MYGN $NVTA - Breaking Down The Invitae Short (Podcast). Get more updates here: https://t.co/jdFCwzvlAO #stockmarket #trading #finance
November 11th 2019, 7:11am
MarketChmln @MarketChmln
$MYGN upcoming event November 08: 2019 American College of Rheumatology (ACR) Annual Meeting. Options expiring on N… https://t.co/1Y5p9WQtSf
November 10th 2019, 4:11pm
Tickeron @Tickeron
$MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/nckMBMiLtF
November 10th 2019, 4:11pm
Gambiste1 @Gambiste1
RT @otcdynamics: $MYGN ROSEN, A LEADING GLOBAL LAW FIRM, Reminds Myriad Genetics, Inc. Investors of Important Deadline in Securities https:…
November 10th 2019, 2:11pm
otcdynamics @otcdynamics
$MYGN ROSEN, A LEADING GLOBAL LAW FIRM, Reminds Myriad Genetics, Inc. Investors of Important Deadline in Securities https://t.co/cLBVF9WWb2
November 10th 2019, 1:11pm
ChartMill @ChartMill
$MYGN has a Return On Assets of -0.96%. This is amongst the best returns in the industry. https://t.co/3nZBYfTiwz https://t.co/IcHHjl2SGS
November 10th 2019, 10:11am
ThisLincolnian @ThisLincolnian
Q2 2020 EPS Estimates for Myriad Genetics, Inc. Decreased by Svb Leerink $MYGN https://t.co/aWHM5hbVkZ
November 10th 2019, 10:11am
TheMarketsDaily @TheMarketsDaily
Zacks: Analysts Expect Myriad Genetics, Inc. $MYGN to Post $0.34 Earnings Per Share https://t.co/ozGWf4sJ6L
November 9th 2019, 10:11pm
TranscriptDaily @TranscriptDaily
Zacks: Analysts Anticipate Myriad Genetics, Inc. $MYGN Will Post Quarterly Sales of $209.24 Million https://t.co/UU5Kkz9Xfc
November 9th 2019, 10:11pm
stocknewstimes @stocknewstimes
Myriad Genetics, Inc. $MYGN Expected to Post Earnings of $0.34 Per Share https://t.co/134c1ucNg2
November 9th 2019, 9:11pm
Tickeron @Tickeron
$MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/VJO3uM3jaR
November 9th 2019, 5:11pm
HottestStockNow @HottestStockNow
New Studies Show the Predictive Value of $MYGN 's Vectra Test in People Diagnosed with Rheumatoid Arthritis… https://t.co/e0euDw4fC5
November 9th 2019, 5:11pm
dailypoliticaln @dailypoliticaln
Myriad Genetics $MYGN Given New $22.00 Price Target at Piper Jaffray Companies https://t.co/ymJowOtYKJ
November 9th 2019, 5:11pm
stocknewstimes @stocknewstimes
Myriad Genetics $MYGN Given New $22.00 Price Target at Piper Jaffray Companies https://t.co/NLoGpLhkWU
November 9th 2019, 5:11pm
TranscriptDaily @TranscriptDaily
Myriad Genetics $MYGN Given New $22.00 Price Target at Piper Jaffray Companies https://t.co/Y4MsHDofaP
November 9th 2019, 5:11pm
Gambiste1 @Gambiste1
RT @newsfilterio: New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis $MYGN http…
November 9th 2019, 5:11pm
Gambiste1 @Gambiste1
RT @otcdynamics: $MYGN New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis https…
November 9th 2019, 5:11pm
otcdynamics @otcdynamics
$MYGN New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis https://t.co/JnynYCVSZU
November 9th 2019, 5:11pm
dakotafinancial @dakotafinancial
Needham & Company LLC Reaffirms Hold Rating for Myriad Genetics $MYGN https://t.co/mZzRktNTls
November 9th 2019, 5:11pm
newsfilterio @newsfilterio
New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis $MYGN https://t.co/mhHSUFe17y
November 9th 2019, 4:11pm
WeekHerald @WeekHerald
Leerink Swann Trims Myriad Genetics $MYGN Target Price to $28.00 https://t.co/Vn1r8ZyN9z
November 9th 2019, 4:11pm
TheMarketsDaily @TheMarketsDaily
Myriad Genetics’ $MYGN Hold Rating Reiterated at Needham & Company LLC https://t.co/SlKAAiNYoR
November 9th 2019, 4:11pm
dispatchtribune @dispatchtribune
Leerink Swann Trims Myriad Genetics $MYGN Target Price to $28.00 https://t.co/oVBzTQ1peP
November 9th 2019, 4:11pm
OlympiaReport @OlympiaReport
Piper Jaffray Companies Trims Myriad Genetics $MYGN Target Price to $22.00 https://t.co/xywySfSyb5
November 9th 2019, 4:11pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.